Franklin Resources’s Tourmaline Bio TRML Stock Holding History

Franklin Resources’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,984	Closed	-$621K	–	3267
2025 Q3	$621K	Sell	12,984 -922	-7%	-$25.6K	﹤0.01%	2326
2025 Q2	$222K	Buy	13,906 +14	+0.1%	+$227	﹤0.01%	2705
2025 Q1	$211K	Buy	+13,892	New	+$223K	﹤0.01%	2656

Franklin Resources's TRML Position: Q4 2025 in Review

Franklin Resources sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 12,984 shares — an estimated $621K sold.

Franklin Resources first reported a position in TRML in Q1 2025 and held it in 3 quarters. The position peaked at $621K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Franklin Resources reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Franklin Resources sold 12,984 Tourmaline Bio shares in Q4 2025, an estimated $621K.
Franklin Resources first reported a position in Tourmaline Bio in Q1 2025 and held it in 3 quarters.
Franklin Resources's Tourmaline Bio position peaked at $621K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Franklin Resources's 13F filing for Q4 2025, filed 11 Feb 2026.